Organotellurium(IV) compounds have been reported to have multiple biological activities including cysteine protease-inhibitory activity, mainly cathepsin B. As cathepsin B is a highly predictive indicator for prognosis and diagnosis of cancer, a possible antitumor potential for these new compounds is expected. In this work, it was investigated the effectiveness of organotellurium(IV) RT-04 to produce lethal effects in the human promyelocytic leukaemia cell line HL60. Using the MTT tetrazolium reduction test, and trypan blue exclusion assay, the IC50 for the compound after 24 h incubation was 6.8 and 0.35 μM, respectively. Moreover, the compound was found to trigger apoptosis in HL60 cells, inducing DNA fragmentation and caspase-3, -6, and -9 activations. The apoptsosis-induced by RT-04 is probably related to the diminished Bcl-2 expression, observed by RT-PCR, in HL60-treated cells. In vivo studies demonstrated that the RT-04 treatment (2.76 mg/kg given for three consecutive days) produces no significant toxic effects for bone marrow and spleen CFU-GM. However, higher doses (5.0 and 10 mg/kg) produced a dose-dependent reduction in the number of CFU-GM of RT-04-treated mice. These results suggest that RT-04 is able to induce apoptosis in HL60 cells by Bcl-2 expression down-modulation. Further studies are necessary to better clarify the effects of this compound on bone marrow normal cells. © 2008 Elsevier Ltd. All rights reserved.46725402545Alonso, S., Minty, A., Bourlet, Y., Buckingham, M., Comparison of three actin-coding sequences in the mouseevolutionary relationships between the actin genes of warm-blooded vertebrates (1986) J. Mol. Evol., 23, pp. 11-22Baum, C., Fairbairn, L.J., Hildinger, M., Lashford, L.S., Hegewisch-Becker, S., Rafferty, J.A., New perspectives for cancer chemotherapy by genetic protection of haematopoietic cells (1999) Expert Rev. Mol. Med., 12, pp. 1-28Brito, J.M., Borojevic, R., Liver granulomas in schistosomiasis: mast cell-dependent induction of SCF expression in hepatic satellite cells is mediated by TNF-alpha (1997) J. Leuk. Biol., 62, pp. 389-396Cao, G., Xiao, M., Sun, F., Xiao, X., Pei, W., Li, J., Graham, S.H., Chen, J., Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death (2004) J. Neurosci., 24, pp. 6189-6201Chen, F., Vallyathan, V., Castranova, V., Shi, X., Cell apoptosis induced by carcinogenic metals (2001) Mol. Cell Biochem., 222, pp. 183-188Chen, M., Wang, J., Initiator caspases in apoptosis signaling pathways (2002) Apoptosis, 4, pp. 313-319Cohen, G.M., Caspases: the executioners of apoptosis (1997) Biochem. J., 326, pp. 1-16Cunha, R.L.O.R., Urano, M.E., Chagas, J.R., Almeida, P.C., Bincoletto, C., Tersariol, I.L.S., Comasseto, J.V., Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B (2005) Bioorg. Med. Chem. Lett., 15, pp. 755-760Engman, L., Al-Maharik, N., McNaughton, M., Birmingham, A., Powis, G., Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells (2003) Bioorg. Med. Chem., 11, pp. 5091-5100Fesik, S.W., Promoting apoptosis as a strategy for cancer drugs discovery (2005) Nat. Rev., 5, pp. 876-885Frei, G.M., Lebenthal, I., Albeck, M., Albeck, A., Sredni, B., Neutral and positively charged thiols synergize the effect of the immunomodulator AS101 as a growth inhibitor of Jurkat cells, by increasing its uptake (2007) Biochem. Pharmacol., 74, pp. 712-722Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100, pp. 57-70Harrison, P.R., Lanfear, J., Wu, L., Fleming, J., McGarry, L., Blower, L., Chemopreventive and growth inhibitory effects of selenium (1997) Biomed. Environ. Sci., 10, pp. 235-245Jiang, X., Wang, X., Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1 (2000) J. Biol. Chem., 275, pp. 31199-31203Liu, X., Zou, H., Slaughter, C., Wang, X., DFF a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis (1997) Cell, 89, pp. 175-184Lovschall, H., Eiskjaer, M., Arenholt-Bindslev, D., Formaldehyde cytotoxicity in three human cell types assessed in three different assays (2002) Toxicol. In Vitro, 16, pp. 63-69Malerba, I., Casati, S., Diodovich, C., Parent-Massin, D., Gribaldo, L., Inhibition of CFU-E/BFU-E and CFU-GM colony growth by cyclophosphamide, 5-fluorouracil and taxol: development of a high-throughput in vitro method (2004) Toxicol. In Vitro, 3, pp. 293-300McNaughton, M., Engman, L., Birmingham, A., Powis, G., Cotgreave, I.A., Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth (2004) J. Med. Chem., 47, pp. 233-239Metcalf, D., (1984) Clonal Culture of Hemopoietic Cells: Techniques and Applications, , Elsevier, Amsterdam p. 167Minko, T., Kopecková, P., Kopecek, J., Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells (2001) J. Contr. Release, 71, pp. 227-237Mosmmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay (1983) J. Immunol. Meth., 65, pp. 55-63Newell, D.R., Silvester, J., McDowell, C., Burtles, S.S., The Cancer Research UK experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies (2004) Eur. J. Cancer, 40, pp. 899-906. , Cancer Research UKNoda, Y., Suzuki, T., Kahara, A., Yotsuyanagi, A., Hasegawa, T., Hayshi, M., Sofuni, T., Okada, S., In vivo genotoxicity evaluation of dimethylarsinic in Muat™ mouse (2002) Mut. Ras. Gen Toxicol. Muagen., 513, pp. 205-212Nogueira, C.W., Zeni, G., Rocha, J.B., Organoselenium and organotellurium compounds: toxicology and pharmacology (2004) Chem. Rev., 104, pp. 6255-6285Oltersdorf, T., Elmore, S.W., Shoemaker, A.R., An inhibitor of Bcl-2 family proteins induces regression of solid tumours (2005) Nature, 435, pp. 677-681Osorio, L.M., De Santiago, A., Aguilar-Santelises, M., Mellstedt, H., Jondal, M., CD6 ligation modulates Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM (1997) Blood, 89, pp. 2833-2841Pailard, F., Finot, F., Mouche, I., Perez, A., Vericat, J.A., Use of primary cultures of rat hepatocytes to predict toxicity in the early development of new chemical entities (1999) Toxicol. In vitro, 13, pp. 693-700Parent-Massin, D., Relevance of clonogenic assays in hematotoxicology (2001) Cell Biol. Toxicol., 17, pp. 87-94Pessina, A., Albella, B., Bayo, M., Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics (2003) Toxicol. Sci., 75, pp. 355-367Rinehart, J., Adjei, A.A., Lorusso, P.M., Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer (2004) J. Clin. Oncol., 22, pp. 4456-4462Rodriguez, J., Lazebnik, Y., Caspase-9 and APAF-1 form an active holoenzyme (1999) Genes Dev., 13, pp. 3179-3184Sailer, B.L., Liles, N., Dickerson, S., Sumners, S., Chasteen, T.G., Oraganotellurium compound toxicity in a promyelocytic cell line compared to non-tellurium-containing organic analog (2004) Toxicol. In vitro, 18, pp. 475-482Stewart, M.S., Davis, R.L., Walsh, L.P., Pence, B.C., Induction of differentiation and apoptosis by sodium selenite in human colonic carcinoma cells (HT29) (1997) Cancer Lett., 117, pp. 35-40Wei, M.C., Zong, W.X., Cheng, E.H., Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death (2001) Science, 292, pp. 727-730Wieslander, E., Engman, L., Svensjö, E., Antioxidative properties of organotellurium compounds in cell systems (1998) Biochem. Pharmacol., 55, pp. 573-584Zeni, G., Chieffi, A., Cunha, R.L.O.R., Stefani, H.A., Zukerman-Schpector, J., Comasseto, J.V., (1999) Organometallics, 18, pp. 803-806Zimmermann, K.C., Bonzon, C., Green, D.R., The machinery of programmed cell death (2001) Pharmacol. Ther., 92, pp. 57-70